| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activity of interferon-α in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma
|
Armitage, J. O.
|
|
2000
|
11 |
3 |
p. 359-361
|
article
|
| 2 |
A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors
|
Tolcher, A. W.
|
|
2000
|
11 |
3 |
p. 333-338
|
article
|
| 3 |
A. V. Kaisary, G. P. Murphy, L. Denis et al. (eds.), Textbook of Prostate Cancer. Pathology, Diagnosis and Treatment
|
De Cobelli, O.
|
|
2000
|
11 |
3 |
p. 252
|
article
|
| 4 |
Characterization of dihydropyrimidine dehydrogenase on immunohistochemistry in colon carcinoma, and correlation between immunohistochemical score and protein level or messenger RNA expression
|
Takenoue, T.
|
|
2000
|
11 |
3 |
p. 273-279
|
article
|
| 5 |
Docetaxel (Taxotere®)–cisplatin (TC): An effective drug combination in gastric carcinoma
|
Roth, A. D.
|
|
2000
|
11 |
3 |
p. 301-306
|
article
|
| 6 |
Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas
|
Zinzani, P. L.
|
|
2000
|
11 |
3 |
p. 363-365
|
article
|
| 7 |
EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells
|
Casamassimi, A.
|
|
2000
|
11 |
3 |
p. 319-325
|
article
|
| 8 |
Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: A prospective randomised trial
|
Popov, I.
|
|
2000
|
11 |
3 |
p. 343-348
|
article
|
| 9 |
Endometrial mesodermal mixed tumor occurring after tamoxifen treatment: Report on a new case and review of the literature
|
Dumortier, J.
|
|
2000
|
11 |
3 |
p. 355-358
|
article
|
| 10 |
Estimation of dihydropyrimidine dehydrogenase activity: Does it have a role in cancer therapy?
|
Collie-Duguid, E. S. R.
|
|
2000
|
11 |
3 |
p. 255-257
|
article
|
| 11 |
Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours
|
Imam, H.
|
|
2000
|
11 |
3 |
p. 295-300
|
article
|
| 12 |
Germ-cell tumors in childhood and adolescence
|
Göbel, U.
|
|
2000
|
11 |
3 |
p. 263-271
|
article
|
| 13 |
M. R. S. Keshtgar, W. A. Waddington, S. R. Lakhani et al. (eds)., The Sentinel Node in Surgical Oncology
|
Gennari, R.
|
|
2000
|
11 |
3 |
p. 376
|
article
|
| 14 |
MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)
|
Toffoli, G.
|
|
2000
|
11 |
3 |
p. 373-374
|
article
|
| 15 |
NCIC–CTG phase II study of gemcitabine in patients with malignant glioma (IND.94)
|
Gertler, S. Z.
|
|
2000
|
11 |
3 |
p. 315-318
|
article
|
| 16 |
Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study
|
Hong, R.-L.
|
|
2000
|
11 |
3 |
p. 349-354
|
article
|
| 17 |
Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer
|
Caponigro, F.
|
|
2000
|
11 |
3 |
p. 339-342
|
article
|
| 18 |
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome
|
Foulkes, W. D.
|
|
2000
|
11 |
3 |
p. 307-313
|
article
|
| 19 |
Proposing phase I studies: Patients', relatives', nurses' and specialists' perceptions
|
Tomamichel, M.
|
|
2000
|
11 |
3 |
p. 289-294
|
article
|
| 20 |
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
|
Tropé, C.
|
|
2000
|
11 |
3 |
p. 281-288
|
article
|
| 21 |
Relevance of DNA-ploidy as a prognostic instrument for solid tumors
|
Silvestrini, R.
|
|
2000
|
11 |
3 |
p. 259-261
|
article
|
| 22 |
R. E. Scully (ed)., Histological Typing of Ovarian Tumours
|
Sessa, C.
|
|
2000
|
11 |
3 |
p. 251
|
article
|
| 23 |
Rituximab: Active treatment of central nervous system involvement by non-Hodgkin's lymphoma?
|
Ruhstaller, T. W.
|
|
2000
|
11 |
3 |
p. 374-375
|
article
|
| 24 |
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer
|
Salden, M.
|
|
2000
|
11 |
3 |
p. 327-332
|
article
|
| 25 |
US admits cancer victims among nuclear arms workers; NHS remains in the limelight; 'Globalizers' most worried about global warming; After 50 years, the Dutch Cancer Society enters a new era; Health Care: A top issue for US Democrats in the election year; Perhaps not everyone knows that...
|
|
|
2000
|
11 |
3 |
p. 245-251
|
article
|
| 26 |
Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study
|
Frasci, G.
|
|
2000
|
11 |
3 |
p. 367-371
|
article
|
| 27 |
World summit against cancer for the new millennium: The Charter of Paris
|
Kerr, D.
|
|
2000
|
11 |
3 |
p. 253-254
|
article
|
Journal description